Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition

NCT01386593 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Detoxication, Phase I

Interventions

DRUG: Basel cocktail+(Fluconazole, Ciprofloxacin, Paroxetine)
DRUG: "Basel" Cocktail
DRUG: Basel cocktail + Rifampicin

Sponsor

University Hospital, Basel, Switzerland